
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study”, BMJ Open, vol. 7, p. e012818, 2017.
, “Adverse mental health outcomes in breast cancer survivors compared to women who did not have cancer: systematic review protocol”, Syst Rev, vol. 6, p. 162, 2017.
, “Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database”, Bmj, vol. 344, p. e2697, 2012.
, “Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink”, Br J Clin Pharmacol, vol. 79, pp. 337-50, 2015.
, “Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK”, Lancet Diabetes Endocrinol, vol. 6, pp. 944-953, 2018.
, “Association of Relative Age in the School Year With Diagnosis of Intellectual Disability, Attention-Deficit/Hyperactivity Disorder, and Depression”, JAMA Pediatr, 2019.
, “Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom”, PLoS Med, vol. 18, p. e1003504, 2021.
, “Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care”, PLoS Med, vol. 12, p. e1001925, 2015.
, “Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin-angiotensin system blockers: a UK primary care cohort study”, BMJ Open, vol. 7, p. e018153, 2017.
, “Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals”, Br J Cancer, 2019.
, “Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults”, Lancet, vol. 384, pp. 755-65, 2014.
, “Chronic obstructive pulmonary disease and the risk of 12 cardiovascular diseases: a population-based study using UK primary care data”, Thorax, vol. 73, pp. 877-879, 2018.
, “Completeness and usability of ethnicity data in UK-based primary care and hospital databases”, J Public Health (Oxf), vol. 36, pp. 684-92, 2014.
, “Data Resource Profile: Clinical Practice Research Datalink (CPRD)”, Int J Epidemiol, vol. 44, pp. 827-36, 2015.
, “Development of predictive genetic tests for improving the safety of new medicines: the utilization of routinely collected electronic health records”, Drug Discov Today, vol. 19, pp. 361-6, 2014.
, “Do pre-diagnosis primary care consultation patterns explain deprivation-specific differences in net survival among women with breast cancer? An examination of individually-linked data from the UK West Midlands cancer registry, national screening programme”, BMC Cancer, vol. 17, p. 155, 2017.
, “Effect of beta blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records”, Bmj, vol. 347, p. f6650, 2013.
, “The effect of sibutramine prescribing in routine clinical practice on cardiovascular outcomes: a cohort study in the United Kingdom”, Int J Obes (Lond), vol. 39, pp. 1359-64, 2015.
, “The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort”, Br J Clin Pharmacol, vol. 79, pp. 1020-7, 2015.
, , “Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs”, Br J Clin Pharmacol, vol. 82, pp. 512-21, 2016.
, “Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study”, PLoS Med, vol. 12, p. e1001854, 2015.
, “Herpes zoster risk after 21 specific cancers: population-based case-control study”, Br J Cancer, vol. 116, pp. 1643-1651, 2017.
, “Identification of mental health and quality of life outcomes in primary care databases in the UK: a systematic review”, BMJ Open, vol. 9, p. e029227, 2019.
, “Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data”, Bmj, vol. 353, p. i3283, 2016.
, “Incidence of acute complications of herpes zoster among immunocompetent adults in England: a matched cohort study using routine health data”, Br J Dermatol, 2020.
, “Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort”, PLoS Med, vol. 14, p. e1002457, 2017.
, “Long-term effects of bariatric surgery on acute kidney injury: a propensity-matched cohort in the UK Clinical Practice Research Datalink”, BMJ Open, vol. 8, p. e020371, 2018.
, , “Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models”, Int J Epidemiol, 2019.
, “Optimising case detection within UK electronic health records: use of multiple linked databases for detecting liver injury”, BMJ Open, vol. 6, p. e012102, 2016.
, “Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink”, Bmj, vol. 346, p. f1936, 2013.
, “Partner Bereavement and Detection of Dementia: A UK-Based Cohort Study Using Routine Health Data”, J Alzheimers Dis, 2019.
, “Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink”, PLoS Med, vol. 13, p. e1002037, 2016.
, “Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004-2014”, BMJ Open, vol. 7, p. e014444, 2017.
, “Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study”, BMJ Open, vol. 6, p. e012690, 2016.
, “Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: A matched cohort study using linked English electronic health records data”, EClinicalMedicine, 2020.
, “Proton pump inhibitors and risk of all-cause and cause-specific mortality: a cohort study”, Br J Clin Pharmacol, 2021.
, “Quality of life and mental health in breast cancer survivors compared with non-cancer controls: a study of patient-reported outcomes in the United Kingdom”, J Cancer Surviv, 2020.
, “Quantification of risk factors for herpes zoster: population based case-control study”, Bmj, vol. 348, p. g2911, 2014.
, “Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study”, Neurology, vol. 87, pp. 94-102, 2016.
, “Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study”, J Antimicrob Chemother, vol. 72, pp. 2636-2646, 2017.
, “Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD)”, BMJ Open, vol. 3, p. e003389, 2013.
, “Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK”, J Cancer Surviv, vol. 13, pp. 632-640, 2019.
, “Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data”, Bmj, vol. 368, p. l6987, 2020.
, “Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study”, Bmj, vol. 356, p. j791, 2017.
, “Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink”, BMC Cancer, vol. 18, p. 1018, 2018.
, “Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care”, BMC Med, vol. 18, p. 195, 2020.
, “Type and timing of heralding in ST-elevation and non-ST-elevation myocardial infarction: an analysis of prospectively collected electronic healthcare records linked to the national registry of acute coronary syndromes”, Eur Heart J Acute Cardiovasc Care, vol. 2, pp. 235-45, 2013.
, ,